Better preservation of erectile function in localized prostate cancer patients with modern proton therapy: Is it cost-effective?

Upon assumption-based modeling, the results of current study support the use of proton SBRT in younger localized PC patients who are previously potent, for better preservation of erectile function. The findings await further validation using data from future comparative clinical trials.